// App-Quantinova.ai

P059 : CLARITY: An Analysis of Severity and Frequency of Relapses in Patients with RMS Treated with Cladribine Tablets or Placebo

Researchers

Presenter

  • Gavin Giovannoni

Principal Investigators

  • Sven Schippling

  • Maria Pia Sormani

  • Nicola De Stefano

  • Andrew Galazka

  • Birgit Keller

  • Nektaria Alexandri

Medical Centers

  • 6Neuroimmunology and Multiple Sclerosis Research, University Hospital Zürich and University of Zürich Zürich Switzerland

  • University of Genoa, Genoa, Italy

  • Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy

  • Queen Mary University of London and Blizard Institute Barts and The London School of Medicine and Dentistry London United Kingdom

  • Ares Trading SA, Aubonne, Switzerland

  • Merck KGaA, Darmstadt, Germany

Locations

  • Switzerland

  • Italy

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Cladribine

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved